Postoperative Pain Control for Prostatectomy (TAP)
Prostate Cancer

About this trial
This is an interventional supportive care trial for Prostate Cancer focused on measuring radical prostatectomy
Eligibility Criteria
Inclusion Criteria:
- prostate cancer for radical prostatectomy
Exclusion Criteria:
- chronic pain or opiate use
Sites / Locations
- Queen Elizabeth Health Sciences Centre
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
TAP arm
standard post operative pain control
in the experimental arm, the procedure will consist of the staff urologist injecting local anesthetic into the anterior abdominal wall bilaterally from the inside of the abdomen at the end of their surgery
Our current post operative analgesic strategy involves a multi-modal approach, using local injectable anesthetic around the incision and systemic medications (i.e. non-steroidal anti-inflammatories, acetaminophen and break-through doses of opiates). Some of the more common adverse reactions are reparatory depression, sedation, confusion, delirium, nausea, pruritis, constipation, hypotension and bradycardia. Often it is these resulting side effects that extend the length of in hospital rehabilitation, and decrease a patient's overall satisfaction.